Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock

Kiniksa Pharmaceuticals, Ltd. (KNSA) is a Healthcare stock trading at $55.22 (as of 2026-06-18), with a market capitalization of $3.99B and a trailing P/E of 53.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Kiniksa Pharmaceuticals, Ltd. is a biopharmaceutical company engaged in discovering, acquiring, developing, and commercializing therapeutic medicines for patients with debilitating conditions and unmet medical needs. Its pipeline includes ARCALYST for recurrent pericarditis, mavrilimumab for giant cell arteritis, vixarelimab for prurigo nodularis, and KPL-404 for immune-related indications.

Valuation — source: SEC EDGAR (first-party)
Price$55.22
Market Cap$3.99B
P/E Ratio53.2
EV / EBITDA40.0
Price / Book6.58
Price / Sales5.29
DCF Value (model)$31.50
DCF Upside vs Price-43.0%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$677.56M
Net Margin8.7%
Return on Equity12.1%
Current Ratio3.79
Revenue Growth (YoY)60.1%
EPS Growth (YoY)-233.3%
FCF Growth (YoY)436.8%
Financial Health — source: SEC EDGAR
Altman Z-Score14.33 (safe)
Valuation vs Sector & Industry
Stock P/E53.2
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector153.7%
vs Industry208.0%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderFMR LLC ($328.56M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOSanj K. Patel
Employees315
CountryBM
IPO Date2018-05-25

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Arcutis Biotherapeutics, Inc. (ARQT)
  • CG Oncology, Inc. Common stock (CGON)
  • Dyne Therapeutics, Inc. (DYN)
  • IDEAYA Biosciences, Inc. (IDYA)
  • Nuvation Bio Inc. (NUVB)
  • Disc Medicine, Inc. (IRON)
  • Arcus Biosciences, Inc. (RCUS)
  • Mineralys Therapeutics, Inc. (MLYS)
KNSA earnings history · KNSA institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.